These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7216372)

  • 21. High-salt diet upregulates kininogen and downregulates tissue kallikrein expression in Dahl-SS and SHR rats.
    Wang C; Chao C; Chen LM; Chao L; Chao J
    Am J Physiol; 1996 Oct; 271(4 Pt 2):F824-30. PubMed ID: 8898012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between AVP and sympathetic system in subtotal nephrectomy-saline hypertension: role of alpha and V1 receptors.
    Ozaykan B; Doğan A
    J Auton Nerv Syst; 2000 Jan; 78(2-3):165-71. PubMed ID: 10789696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of endothelial cell function by chronic cicletanine treatment in Dahl salt-sensitive rats with salt-induced hypertension.
    Hirawa N; Uehara Y; Kawabata Y; Akie Y; Ichikawa A; Funahashi N; Goto A; Omata M
    Hypertens Res; 1996 Dec; 19(4):263-70. PubMed ID: 8986457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence against a vasopressor role of ADH in malignant DOC-salt hypertension.
    Filep J; Frölich JC; Fejes-Toth G
    Clin Exp Hypertens A; 1985; 7(10):1457-70. PubMed ID: 3841034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma and renal prorenin/renin, renin mRNA, and blood pressure in Dahl salt-sensitive and salt-resistant rats.
    Campbell WG; Gahnem F; Catanzaro DF; James GD; Camargo MJ; Laragh JH; Sealey JE
    Hypertension; 1996 May; 27(5):1121-33. PubMed ID: 8621206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats.
    Rapp JP; Dene H
    Hypertension; 1985; 7(3 Pt 1):340-9. PubMed ID: 3997219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3H-norepinephrine release in hypothalamus and brainstem of Dahl-salt sensitive and resistant rats in vitro.
    Meldrum MJ; Westfall TC
    Clin Exp Hypertens A; 1986; 8(8):1395-411. PubMed ID: 3815859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AT(1) receptor regulation in salt-sensitive hypertension.
    Strehlow K; Nickenig G; Roeling J; Wassmann S; Zolk O; Knorr A; Böhm M
    Am J Physiol; 1999 Nov; 277(5):H1701-7. PubMed ID: 10564122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered peripheral noradrenergic activity in intact and sinoaortic denervated Dahl rats.
    Peuler JD; Patel KP; Morgan DA; Whiteis CA; Lund DD; Pardini BJ; Schmid PG
    Can J Physiol Pharmacol; 1989 May; 67(5):442-9. PubMed ID: 2766092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CNS-induced natriuresis, neurohypophyseal peptides and renal dopamine and noradrenaline excretion in prehypertensive salt-sensitive Dahl rats.
    Sjöquist M; Lee SL; Hansell P
    Exp Physiol; 2005 Nov; 90(6):847-53. PubMed ID: 16091405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of an anteroventral third ventricle lesion on NaCl hypertension in Dahl salt-sensitive rats.
    Goto A; Ganguli M; Tobian L; Johnson MA; Iwai J
    Am J Physiol; 1982 Oct; 243(4):H614-8. PubMed ID: 7124969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carotid artery mechanical properties of Dahl salt-sensitive rats.
    Benetos A; Bouaziz H; Albaladejo P; Guez D; Safar ME
    Hypertension; 1995 Feb; 25(2):272-7. PubMed ID: 7843778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium regulation of alpha 2-adrenoreceptors in Dahl rats. Effect of feeding a low or high salt diet.
    Periyasamy SM; Rapp JP
    Biochem Pharmacol; 1989 Nov; 38(21):3851-8. PubMed ID: 2557032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that reduced renal medullary nitric oxide synthase activity of dahl s rats enables small elevations of arginine vasopressin to produce sustained hypertension.
    Yuan B; Cowley AW
    Hypertension; 2001 Feb; 37(2 Pt 2):524-8. PubMed ID: 11230329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged inhibition of pressor response to vasopressin by a potent specific antagonist, [1-(beta-mercapto-beta, beta-cyclopentamethylenepropionic acid) 2-(O-methyl)tyrosine]arginine-vasopressin.
    Pang CC; Leighton KM
    Can J Physiol Pharmacol; 1981 Sep; 59(9):1008-12. PubMed ID: 6895346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenteric vascular responses to vasopressin during development of DOCA-salt hypertension in male and female rats.
    Stallone JN
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R40-9. PubMed ID: 7840337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contributions of vasopressin and other pressor systems to DOC-salt hypertension in rats.
    Mento PF; Wang HH; Sawyer WH
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):58-63. PubMed ID: 6694969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of the vascular effect of vasopressin in patients with mild essential hypertension.
    Bussien JP; Waeber B; Nussberger J; Hofbauer KG; Brunner HR
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):130-9. PubMed ID: 3767522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggravation of salt-induced hypertension in Dahl rats by 2% supplemental dietary calcium.
    Peuler JD; Mark AL
    Hypertension; 1989 Jun; 13(6 Pt 2):929-34. PubMed ID: 2567707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.